Intracranial hypertension occurs when pressure inside the skull rises above the normal range of 7 to 15 mmHg, with readings above 20 mmHg considered pathological. The causes fall into two broad categories: cases with an identifiable underlying trigger (secondary intracranial hypertension) and cases where no clear cause is found (idiopathic intracranial hypertension, or IIH). In both types, the core problem involves too much cerebrospinal fluid (CSF) building up because of impaired drainage, increased production, or obstructed blood flow out of the brain.
How Pressure Builds Inside the Skull
Your brain floats in cerebrospinal fluid, a clear liquid that cushions it and carries away waste. This fluid is constantly produced, circulated, and reabsorbed in a tightly regulated cycle. When something disrupts that cycle, fluid accumulates and pressure rises. Three main mechanisms drive this process.
The first is increased resistance to CSF outflow. Normally, CSF drains back into the bloodstream through small structures along the brain’s outer lining. If those drainage pathways become blocked or less efficient, fluid backs up. The second mechanism is elevated pressure in the brain’s venous sinuses, the large veins that carry blood out of the skull. When pressure in these veins rises, CSF needs higher pressure to drain into them, creating a buildup. The third, less common mechanism is overproduction of CSF itself, though research has found limited objective evidence that this plays a major role in most cases.
These mechanisms often interact. For instance, narrowing of the venous sinuses (called transverse sinus stenosis) appears in 10% to 90% of IIH patients, compared to about 7% of the general population. The narrowing may start from a small initial rise in pressure that compresses the sinus wall, which then raises pressure further, which compresses the wall more. This feedback loop can escalate a mild problem into a serious one. Over time, chronic compression causes scarring and permanent remodeling of the sinus wall, making the stenosis self-sustaining even if the original trigger resolves.
Idiopathic Intracranial Hypertension
IIH is the most common form of intracranial hypertension without a tumor, blood clot, or other structural cause. It affects roughly 0.9 per 100,000 people in the general population annually, but that rate jumps to 19 per 100,000 among women aged 20 to 44 who are 20% or more above their ideal weight. The average age at diagnosis is about 30, and over 90% of adult patients are women.
Despite extensive research, no single cause of IIH has been pinpointed. The strongest association is with obesity and recent weight gain. A large multicenter study found a dose-response relationship: the higher a person’s BMI, the greater the risk. Even modest weight gain in the range of 5% to 15% of body weight increased the risk of developing IIH, including in people who were not obese to begin with. This is why weight loss is a cornerstone of treatment, and clinical trials have confirmed it can lower intracranial pressure and push the condition into remission.
The Hormonal Connection
IIH’s strong preference for women of reproductive age has led researchers to investigate hormonal factors. Polycystic ovary syndrome (PCOS) co-exists with IIH in an estimated 15% to 64% of affected women, depending on the study. A population-based study of over 50,000 women found that those with IIH were 1.5 times more likely to have a PCOS diagnosis than matched controls. Both conditions share features like insulin resistance, excess body fat around the trunk, and elevated androgen levels, though they have distinct hormonal profiles.
Other endocrine disorders linked to intracranial hypertension include Addison’s disease (adrenal insufficiency), underactive parathyroid glands, and steroid withdrawal. In children, growth hormone therapy has been associated with raised intracranial pressure.
Secondary Causes
When intracranial hypertension has a clear, identifiable trigger, it’s classified as secondary. Any condition that increases the volume of fluid, tissue, or blood inside the skull, or that obstructs drainage pathways, can be responsible.
Blood Clots in the Brain’s Veins
Cerebral venous sinus thrombosis, a blood clot in the veins draining the brain, is one of the most important secondary causes. The clot physically blocks the outflow of blood and CSF, rapidly increasing pressure. This requires specific treatment to dissolve or manage the clot, and pressure often improves once the blocked vein reopens.
Medications
Several drug classes can raise intracranial pressure. The most well-established include:
- Tetracycline antibiotics (including minocycline and doxycycline), commonly prescribed for acne and infections
- Retinoids and vitamin A, including isotretinoin (used for severe acne), other retinoid medications, and high-dose vitamin A supplements
- Lithium, used for bipolar disorder
- Corticosteroids, particularly during withdrawal after long-term use, and in some cases during treatment (including inhaled steroids used for conditions like Crohn’s disease in children)
- Growth hormone, primarily in pediatric patients
In many medication-related cases, stopping the offending drug or adjusting the dose resolves the pressure elevation. If you’re taking any of these medications and develop persistent headaches or vision changes, that information is important for your doctor to have.
Other Medical Conditions
Sleep apnea is a probable contributor, likely because repeated episodes of low oxygen and high carbon dioxide during sleep dilate blood vessels in the brain and raise venous pressure. Kidney disease (uremia), systemic lupus, and sarcoidosis have also been linked to raised intracranial pressure, though these associations are less firmly established. Iron deficiency anemia is another possible risk factor that appears in the research literature.
How It Differs in Children
Intracranial hypertension in children, especially before puberty, is more likely to have a secondary cause than the idiopathic form seen in adults. The strong female and obesity associations that define adult IIH are much weaker in younger children. Infections, systemic diseases, endocrine problems, and medications are all recognized triggers. For this reason, the diagnostic workup in children tends to be more extensive, searching for an underlying condition rather than defaulting to an IIH diagnosis.
After puberty, the pattern shifts to look more like adult IIH, with a stronger female predominance and closer ties to weight.
What High Pressure Does to Vision
Regardless of the cause, the most concerning consequence of sustained intracranial hypertension is damage to the optic nerves. Elevated pressure transmits along the sheath surrounding each optic nerve, causing the nerve head at the back of the eye to swell. This swelling, called papilledema, disrupts the normal flow of nutrients and signals within the nerve fibers and physically compresses the nerve from the outside.
Early papilledema may cause no noticeable vision problems at all, which is why it’s often caught during a routine eye exam before a patient suspects anything is wrong. As it progresses, you might notice brief episodes of vision going gray or black (lasting seconds), blind spots, or blurred vision. Without treatment, chronic papilledema can lead to permanent, sometimes profound, vision loss. This is the primary reason intracranial hypertension requires monitoring and management even when headaches are the only symptom.
Why Obesity Plays Such a Central Role
The relationship between body weight and intracranial pressure is the single most consistent finding in IIH research, yet the exact mechanism remains unclear. Several theories exist. Excess abdominal fat may increase pressure in the chest and abdomen, which raises pressure in the veins draining the brain. Obesity-related hormonal and metabolic changes, including insulin resistance and altered androgen levels, may affect how CSF is produced or absorbed. Fat tissue is also metabolically active, producing inflammatory signals that could influence fluid dynamics in the brain.
What is clear from clinical evidence is that the relationship is not just about being heavy. It’s about change. Gaining even a relatively small amount of weight can trigger new or worsening symptoms, while losing weight can bring pressure down. This makes weight management one of the few interventions with strong evidence of directly lowering intracranial pressure in IIH patients, with some achieving full remission through sustained weight loss alone.